{"entity":{"type":"insider","cik":"0001657765","url":"/insider/0001657765","json_url":"/insider/0001657765.json","name":"Moran Kyle","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":14,"n_filings":9,"first":"2021-02-18","last":"2026-02-11","span_basis":"filed_date"},"name_variants":[{"name":"Moran Kyle","source":"filing","n_filings":9,"first_seen":"2021-02-18","last_seen":"2026-02-11"}],"transactions":[{"id":6072660,"accession":"0001193125-26-047323","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-047323","line_url":"/filing/0001193125-26-047323#line-2","is_derivative":false,"issuer_cik":"0001631574","issuer_name":"Wave Life Sciences Ltd.","issuer_ticker":"WVE","issuer_name_source":null,"issuer_url":"/issuer/0001631574","owner_cik":"0001657765","owner_name":"Moran Kyle","owner_display_name":"Moran Kyle","owner_url":"/insider/0001657765","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3588.0,"shares_display":"3,588","price_per_share":13.45,"price_display":"13.45","price_state":"stated","total_value":48258.6,"total_display":"48,258.60","total_whole":"48,259","shares_owned_after":134385.0,"shares_owned_after_display":"134,385","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-09","filed_date":"2026-02-11","scope":"insider"},{"id":4991217,"accession":"0001193125-25-314736","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001193125-25-314736","line_url":"/filing/0001193125-25-314736","is_derivative":false,"issuer_cik":"0001631574","issuer_name":"Wave Life Sciences Ltd.","issuer_ticker":"WVE","issuer_name_source":null,"issuer_url":"/issuer/0001631574","owner_cik":"0001657765","owner_name":"Moran Kyle","owner_display_name":"Moran Kyle","owner_url":"/insider/0001657765","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50036.0,"shares_display":"50,036","price_per_share":20.02516188344392,"price_display":"20.03","price_state":"stated","total_value":1001979.0,"total_display":"1,001,979.00","total_whole":"1,001,979","shares_owned_after":90365.0,"shares_owned_after_display":"90,365","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-09","filed_date":"2025-12-10","scope":"insider","n_lines":2},{"id":4991201,"accession":"0001193125-25-314736","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001193125-25-314736","line_url":"/filing/0001193125-25-314736","is_derivative":false,"issuer_cik":"0001631574","issuer_name":"Wave Life Sciences Ltd.","issuer_ticker":"WVE","issuer_name_source":null,"issuer_url":"/issuer/0001631574","owner_cik":"0001657765","owner_name":"Moran Kyle","owner_display_name":"Moran Kyle","owner_url":"/insider/0001657765","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":210000.0,"shares_display":"210,000","price_per_share":14.771428571428572,"price_display":"14.77","price_state":"stated","total_value":3102000.0,"total_display":"3,102,000.00","total_whole":"3,102,000","shares_owned_after":89218.0,"shares_owned_after_display":"89,218","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-08","filed_date":"2025-12-10","scope":"insider","n_lines":4},{"id":3217266,"accession":"0000950170-24-110141","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-110141","line_url":"/filing/0000950170-24-110141#line-1","is_derivative":false,"issuer_cik":"0001631574","issuer_name":"Wave Life Sciences Ltd.","issuer_ticker":"WVE","issuer_name_source":null,"issuer_url":"/issuer/0001631574","owner_cik":"0001657765","owner_name":"Moran Kyle","owner_display_name":"Moran Kyle","owner_url":"/insider/0001657765","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17146.0,"shares_display":"17,146","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":154314.0,"total_display":"154,314.00","total_whole":"154,314","shares_owned_after":19777.0,"shares_owned_after_display":"19,777","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-25","filed_date":"2024-09-27","scope":"insider"},{"id":2514478,"accession":"0000950170-24-042381","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-042381","line_url":"/filing/0000950170-24-042381#line-1","is_derivative":false,"issuer_cik":"0001631574","issuer_name":"Wave Life Sciences Ltd.","issuer_ticker":"WVE","issuer_name_source":null,"issuer_url":"/issuer/0001631574","owner_cik":"0001657765","owner_name":"Moran Kyle","owner_display_name":"Moran Kyle","owner_url":"/insider/0001657765","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15630.0,"shares_display":"15,630","price_per_share":6.169,"price_display":"6.17","price_state":"stated","total_value":96421.47,"total_display":"96,421.47","total_whole":"96,421","shares_owned_after":33921.0,"shares_owned_after_display":"33,921","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-03","filed_date":"2024-04-05","scope":"insider"},{"id":8644898,"accession":"0000899243-23-018361","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-018361","line_url":"/filing/0000899243-23-018361#line-1","is_derivative":false,"issuer_cik":"0001631574","issuer_name":"Wave Life Sciences Ltd.","issuer_ticker":"WVE","issuer_name_source":null,"issuer_url":"/issuer/0001631574","owner_cik":"0001657765","owner_name":"Moran Kyle","owner_display_name":"Moran Kyle","owner_url":"/insider/0001657765","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37062.0,"shares_display":"37,062","price_per_share":4.752,"price_display":"4.75","price_state":"stated","total_value":176118.624,"total_display":"176,118.62","total_whole":"176,119","shares_owned_after":46120.0,"shares_owned_after_display":"46,120","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-23","filed_date":"2023-08-23","scope":"insider"},{"id":8244208,"accession":"0000899243-23-005562","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-005562","line_url":"/filing/0000899243-23-005562#line-1","is_derivative":false,"issuer_cik":"0001631574","issuer_name":"Wave Life Sciences Ltd.","issuer_ticker":"WVE","issuer_name_source":null,"issuer_url":"/issuer/0001631574","owner_cik":"0001657765","owner_name":"Moran Kyle","owner_display_name":"Moran Kyle","owner_url":"/insider/0001657765","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9729.0,"shares_display":"9,729","price_per_share":4.04,"price_display":"4.04","price_state":"stated","total_value":39305.16,"total_display":"39,305.16","total_whole":"39,305","shares_owned_after":79751.0,"shares_owned_after_display":"79,751","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-16","filed_date":"2023-02-17","scope":"insider"},{"id":6341595,"accession":"0000899243-22-017133","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-017133","line_url":"/filing/0000899243-22-017133#line-2","is_derivative":false,"issuer_cik":"0001631574","issuer_name":"Wave Life Sciences Ltd.","issuer_ticker":"WVE","issuer_name_source":null,"issuer_url":"/issuer/0001631574","owner_cik":"0001657765","owner_name":"Moran Kyle","owner_display_name":"Moran Kyle","owner_url":"/insider/0001657765","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5021.0,"shares_display":"5,021","price_per_share":1.72,"price_display":"1.72","price_state":"stated","total_value":8636.12,"total_display":"8,636.12","total_whole":"8,636","shares_owned_after":84567.0,"shares_owned_after_display":"84,567","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-05","filed_date":"2022-05-06","scope":"insider"},{"id":6913565,"accession":"0000899243-22-007066","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-007066","line_url":"/filing/0000899243-22-007066#line-1","is_derivative":false,"issuer_cik":"0001631574","issuer_name":"Wave Life Sciences Ltd.","issuer_ticker":"WVE","issuer_name_source":null,"issuer_url":"/issuer/0001631574","owner_cik":"0001657765","owner_name":"Moran Kyle","owner_display_name":"Moran Kyle","owner_url":"/insider/0001657765","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9204.0,"shares_display":"9,204","price_per_share":2.31,"price_display":"2.31","price_state":"stated","total_value":21261.24,"total_display":"21,261.24","total_whole":"21,261","shares_owned_after":74588.0,"shares_owned_after_display":"74,588","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-16","filed_date":"2022-02-18","scope":"insider"},{"id":4866990,"accession":"0000899243-21-007201","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-007201","line_url":"/filing/0000899243-21-007201#line-2","is_derivative":false,"issuer_cik":"0001631574","issuer_name":"Wave Life Sciences Ltd.","issuer_ticker":"WVE","issuer_name_source":null,"issuer_url":"/issuer/0001631574","owner_cik":"0001657765","owner_name":"Moran Kyle","owner_display_name":"Moran Kyle","owner_url":"/insider/0001657765","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1722.0,"shares_display":"1,722","price_per_share":10.57,"price_display":"10.57","price_state":"stated","total_value":18201.54,"total_display":"18,201.54","total_whole":"18,202","shares_owned_after":69862.0,"shares_owned_after_display":"69,862","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-16","filed_date":"2021-02-18","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":14,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":14,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":14},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001631574","name":"Wave Life Sciences Ltd.","url":"/issuer/0001631574","role":"Officer (Chief Financial Officer)","n_filings":9,"first_seen":"2021-02-18","last_seen":"2026-02-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001657765","retrieved_at":"2026-08-25T15:14:17+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}